Meguro 2007b.
Study characteristics | |||
Patient Sampling | This reference have two incidence studies (called Meguro 2007a and Meguro 2007b for this review). In the 2005 study (Meguro 2007b), 281 patients without MRI results were analysed Exclusion criteria: not reported |
||
Patient characteristics and setting | A total of 281 participants with MCI ('questionable dementia') diagnosed with CDR = 0.5 (Morris 1993) were included in 2005 study. Those participants were recruited from the same community based population. Demographic data presented for the MCI‐converters (n=133; Table 1, p178) was provided for both studies (Meguro 2007a and Meguro 2007b): Gender: 45 M; 88 F Age: 9 aged 65 to 69 years; 77 aged 70 to 79 years; 47 aged 80+ Sources of recruitment: community of Tajiri, Japan |
||
Index tests | Mini‐Mental state Examination (MMSE): Folstein version (1975, reference 25). A team of trained psychologist performed MMSE blindly to the diagnosis and CDR Threshold: “Abnormal MMSE data are assessed with reference to the participants’ educational levels based on the old Japanese education system: 17/18 for 6 (or less) years of schooling, 20/21 for 8 years of schooling, and 23/24 for 10 (or more) years of schooling” (information provided from the author) Cut off: ˂ 17 or ˂ 20 or ˂ 23 |
||
Target condition and reference standard(s) | Target condition: conversion from MCI to dementia Reference standard: DSM‐IV and CDR 1 +. A clinical team comprising medical doctors and public health nurses determined the follow‐up CDR blindly to the previous CDR stages, baseline cognitive test scores, and MRI data |
||
Flow and timing |
Participants 2005 (at baseline): N = 281 Duration of follow‐up: 7 years At follow‐up: 113 MCI‐dementia: 26 with abnormal MMSE (at baseline); 168 MCI‐stable: 14 with abnormal MMSE (at baseline) (information from the author) TP = 26; FN = 87; FP = 14; TN = 154 Sensitivity = 23%; Specificity = 92% (calculated in RevMan5) Loss to follow‐up: none |
||
Comparative | |||
Notes | The trial investigators were contacted; they provided requested data tor the 2 X 2 table to be completed; e‐mail from Dr Meguro on 4 March 2014 | ||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Unclear | ||
Was a case‐control design avoided? | Yes | ||
Did the study avoid inappropriate exclusions? | Unclear | ||
Could the selection of patients have introduced bias? | High risk | ||
Are there concerns that the included patients and setting do not match the review question? | Low concern | ||
DOMAIN 3: Reference Standard | |||
Is the assessment used for clinical diagnosis of dementia acceptable? | Yes | ||
Was clinical assessment for dementia performed without knowledge of the MMSE results? | Yes | ||
Could the reference standard, its conduct, or its interpretation have introduced bias? | Low risk | ||
Are there concerns that the target condition as defined by the reference standard does not match the question? | Low concern | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between MMSE and the reference standard? | Yes | ||
Did all participants receive the same reference standard? | Yes | ||
Were all participants included in the final analysis? | Yes | ||
Could the patient flow have introduced bias? | Low risk |